Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination

Robert M A Hirschfeld, David L. Dunner, Gabor Keitner, Daniel N. Klein, Lorrin M. Koran, Susan G. Kornstein, John C. Markowitz, Ivan Miller, Charles B. Nemeroff, Philip T. Ninan, A. John Rush, Alan F. Schatzberg, Michael E. Thase, Madhukar H. Trivedi, Frances E. Borian, Paul Crits-Christoph, Martin B. Keller

Research output: Contribution to journalArticle

157 Citations (Scopus)

Abstract

Background: Although it is known that antidepressant treatment improves psychosocial functioning, whether such changes occur independent of depressive symptoms is not known. This study compared efficacy of nefazodone, psychotherapy, and their combination in improving psychosocial functioning in chronically depressed outpatients. Methods: Patients with chronic forms of major depressive disorder were randomized to 12 weeks of nefazodone, Cognitive Behavioral Analysis System of Psychotherapy (CBASP), or combined nefazodone/CBASP. Psychosocial assessments measured overall psychosocial functioning, work functioning, interpersonal functioning, and general health. Results: Relative to community norms, patients with chronic major depression evidenced substantially impaired psychosocial functioning at baseline. Combined treatment produced significantly greater psychosocial improvement than either CBASP alone or nefazodone alone on all primary measures. Combined treatment remained superior to nefazodone on primary measures of work, social, and overall functioning, and superior to CBASP on social functioning when depressive symptoms were controlled. Unlike the two groups receiving nefazodone, CBASP alone's effect on psychosocial function was relatively independent of symptom change. Psychosocial functioning improved more slowly than depressive symptoms, and moderate psychosocial impairments remained at end point. Conclusions: Combined treatment had greater effect than either monotherapy. Change in depressive symptoms did not fully explain psychosocial improvement. Moderate residual psychosocial impairment remained, suggesting the need for continuation/maintenance treatment.

Original languageEnglish (US)
Pages (from-to)123-133
Number of pages11
JournalBiological Psychiatry
Volume51
Issue number2
DOIs
StatePublished - Jan 15 2002

Fingerprint

Psychotherapy
Depression
Therapeutics
Major Depressive Disorder
Antidepressive Agents
nefazodone
Outpatients
Health

Keywords

  • Chronic major depression
  • Combined treatment
  • Nefazodone
  • Psychosocial functioning
  • Psychotherapy

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

Hirschfeld, R. M. A., Dunner, D. L., Keitner, G., Klein, D. N., Koran, L. M., Kornstein, S. G., ... Keller, M. B. (2002). Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination. Biological Psychiatry, 51(2), 123-133. https://doi.org/10.1016/S0006-3223(01)01291-4

Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination. / Hirschfeld, Robert M A; Dunner, David L.; Keitner, Gabor; Klein, Daniel N.; Koran, Lorrin M.; Kornstein, Susan G.; Markowitz, John C.; Miller, Ivan; Nemeroff, Charles B.; Ninan, Philip T.; Rush, A. John; Schatzberg, Alan F.; Thase, Michael E.; Trivedi, Madhukar H.; Borian, Frances E.; Crits-Christoph, Paul; Keller, Martin B.

In: Biological Psychiatry, Vol. 51, No. 2, 15.01.2002, p. 123-133.

Research output: Contribution to journalArticle

Hirschfeld, RMA, Dunner, DL, Keitner, G, Klein, DN, Koran, LM, Kornstein, SG, Markowitz, JC, Miller, I, Nemeroff, CB, Ninan, PT, Rush, AJ, Schatzberg, AF, Thase, ME, Trivedi, MH, Borian, FE, Crits-Christoph, P & Keller, MB 2002, 'Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination', Biological Psychiatry, vol. 51, no. 2, pp. 123-133. https://doi.org/10.1016/S0006-3223(01)01291-4
Hirschfeld, Robert M A ; Dunner, David L. ; Keitner, Gabor ; Klein, Daniel N. ; Koran, Lorrin M. ; Kornstein, Susan G. ; Markowitz, John C. ; Miller, Ivan ; Nemeroff, Charles B. ; Ninan, Philip T. ; Rush, A. John ; Schatzberg, Alan F. ; Thase, Michael E. ; Trivedi, Madhukar H. ; Borian, Frances E. ; Crits-Christoph, Paul ; Keller, Martin B. / Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination. In: Biological Psychiatry. 2002 ; Vol. 51, No. 2. pp. 123-133.
@article{5cfccb2e683d41a68b8d8e442b5c71c9,
title = "Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination",
abstract = "Background: Although it is known that antidepressant treatment improves psychosocial functioning, whether such changes occur independent of depressive symptoms is not known. This study compared efficacy of nefazodone, psychotherapy, and their combination in improving psychosocial functioning in chronically depressed outpatients. Methods: Patients with chronic forms of major depressive disorder were randomized to 12 weeks of nefazodone, Cognitive Behavioral Analysis System of Psychotherapy (CBASP), or combined nefazodone/CBASP. Psychosocial assessments measured overall psychosocial functioning, work functioning, interpersonal functioning, and general health. Results: Relative to community norms, patients with chronic major depression evidenced substantially impaired psychosocial functioning at baseline. Combined treatment produced significantly greater psychosocial improvement than either CBASP alone or nefazodone alone on all primary measures. Combined treatment remained superior to nefazodone on primary measures of work, social, and overall functioning, and superior to CBASP on social functioning when depressive symptoms were controlled. Unlike the two groups receiving nefazodone, CBASP alone's effect on psychosocial function was relatively independent of symptom change. Psychosocial functioning improved more slowly than depressive symptoms, and moderate psychosocial impairments remained at end point. Conclusions: Combined treatment had greater effect than either monotherapy. Change in depressive symptoms did not fully explain psychosocial improvement. Moderate residual psychosocial impairment remained, suggesting the need for continuation/maintenance treatment.",
keywords = "Chronic major depression, Combined treatment, Nefazodone, Psychosocial functioning, Psychotherapy",
author = "Hirschfeld, {Robert M A} and Dunner, {David L.} and Gabor Keitner and Klein, {Daniel N.} and Koran, {Lorrin M.} and Kornstein, {Susan G.} and Markowitz, {John C.} and Ivan Miller and Nemeroff, {Charles B.} and Ninan, {Philip T.} and Rush, {A. John} and Schatzberg, {Alan F.} and Thase, {Michael E.} and Trivedi, {Madhukar H.} and Borian, {Frances E.} and Paul Crits-Christoph and Keller, {Martin B.}",
year = "2002",
month = "1",
day = "15",
doi = "10.1016/S0006-3223(01)01291-4",
language = "English (US)",
volume = "51",
pages = "123--133",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination

AU - Hirschfeld, Robert M A

AU - Dunner, David L.

AU - Keitner, Gabor

AU - Klein, Daniel N.

AU - Koran, Lorrin M.

AU - Kornstein, Susan G.

AU - Markowitz, John C.

AU - Miller, Ivan

AU - Nemeroff, Charles B.

AU - Ninan, Philip T.

AU - Rush, A. John

AU - Schatzberg, Alan F.

AU - Thase, Michael E.

AU - Trivedi, Madhukar H.

AU - Borian, Frances E.

AU - Crits-Christoph, Paul

AU - Keller, Martin B.

PY - 2002/1/15

Y1 - 2002/1/15

N2 - Background: Although it is known that antidepressant treatment improves psychosocial functioning, whether such changes occur independent of depressive symptoms is not known. This study compared efficacy of nefazodone, psychotherapy, and their combination in improving psychosocial functioning in chronically depressed outpatients. Methods: Patients with chronic forms of major depressive disorder were randomized to 12 weeks of nefazodone, Cognitive Behavioral Analysis System of Psychotherapy (CBASP), or combined nefazodone/CBASP. Psychosocial assessments measured overall psychosocial functioning, work functioning, interpersonal functioning, and general health. Results: Relative to community norms, patients with chronic major depression evidenced substantially impaired psychosocial functioning at baseline. Combined treatment produced significantly greater psychosocial improvement than either CBASP alone or nefazodone alone on all primary measures. Combined treatment remained superior to nefazodone on primary measures of work, social, and overall functioning, and superior to CBASP on social functioning when depressive symptoms were controlled. Unlike the two groups receiving nefazodone, CBASP alone's effect on psychosocial function was relatively independent of symptom change. Psychosocial functioning improved more slowly than depressive symptoms, and moderate psychosocial impairments remained at end point. Conclusions: Combined treatment had greater effect than either monotherapy. Change in depressive symptoms did not fully explain psychosocial improvement. Moderate residual psychosocial impairment remained, suggesting the need for continuation/maintenance treatment.

AB - Background: Although it is known that antidepressant treatment improves psychosocial functioning, whether such changes occur independent of depressive symptoms is not known. This study compared efficacy of nefazodone, psychotherapy, and their combination in improving psychosocial functioning in chronically depressed outpatients. Methods: Patients with chronic forms of major depressive disorder were randomized to 12 weeks of nefazodone, Cognitive Behavioral Analysis System of Psychotherapy (CBASP), or combined nefazodone/CBASP. Psychosocial assessments measured overall psychosocial functioning, work functioning, interpersonal functioning, and general health. Results: Relative to community norms, patients with chronic major depression evidenced substantially impaired psychosocial functioning at baseline. Combined treatment produced significantly greater psychosocial improvement than either CBASP alone or nefazodone alone on all primary measures. Combined treatment remained superior to nefazodone on primary measures of work, social, and overall functioning, and superior to CBASP on social functioning when depressive symptoms were controlled. Unlike the two groups receiving nefazodone, CBASP alone's effect on psychosocial function was relatively independent of symptom change. Psychosocial functioning improved more slowly than depressive symptoms, and moderate psychosocial impairments remained at end point. Conclusions: Combined treatment had greater effect than either monotherapy. Change in depressive symptoms did not fully explain psychosocial improvement. Moderate residual psychosocial impairment remained, suggesting the need for continuation/maintenance treatment.

KW - Chronic major depression

KW - Combined treatment

KW - Nefazodone

KW - Psychosocial functioning

KW - Psychotherapy

UR - http://www.scopus.com/inward/record.url?scp=0037081370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037081370&partnerID=8YFLogxK

U2 - 10.1016/S0006-3223(01)01291-4

DO - 10.1016/S0006-3223(01)01291-4

M3 - Article

C2 - 11822991

AN - SCOPUS:0037081370

VL - 51

SP - 123

EP - 133

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 2

ER -